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Background. We set out to identify the level of previous exposure to influenza A (H1N1) in unvaccinated healthcare workers
(HCWs) at the peak of the pandemic outbreak in the UK, with control samples collected prior to the outbreak. Methods. Cross-
sectional study (seroprevalence assessed before and at pandemic peak, with questionnaire data collected at peak of outbreak)
in HCWs in Scotland. Results. The prevalence of seropositivity in 493 HCWs at pandemic peak was 10.3%, which was higher
than the prepandemic level by 3.7 percentage points (95% CI 0.3% to 7.3%, P = 0.048). Seropositivity rates for frontline and
nonfrontline HCWs were similar. Conclusion. At pandemic peak, only 10.3% of HCWs were seropositive for influenza A (H1N1),
so the great majority were still susceptible to infection at the introduction of the vaccination programme. Few studies have reported
on seroprevalence in unvaccinated and asymptomatic participants, so our findings may have relevance to the wider population.
1. Introduction
The susceptibility of healthcare workers (HCW) to influenza
is relevant in terms of sickness absence, productivity, and
onward transmission of infection from carer to patient [1],
a particular issue with a novel influenza strain. The first
cases of 2009 pandemic influenza A (H1N1) were identified
in Scotland in April 2009 [2]. We set out to determine the
seroprevalence of antibodies against the virus in unvacci-
nated HCWs in Lothian, south east Scotland in Autumn
2009 (after the first wave of infection, but before the expected
increase in cases over the winter period). It is now clear that
this was close to the peak of the outbreak in the United
Kingdom (UK) [3].
2. Materials and Methods
Between 29/10/2009 and 4/11/2009 (at the time believed
to be midpandemic, but now known to have been peak),
unvaccinated NHS Lothian employees (n = 505) were
recruited within days of the start of the HCW vaccination
programme and prior to most HCWs being vaccinated.
Recruitment was mainly from three acute teaching hospitals,
with smaller numbers from a psychiatric hospital and the
Health Board headquarters. After giving informed consent
participants had a serum sample taken and completed a
short questionnaire recording sex, age, occupation, and self-
reported history of flu-like symptoms or illness since the start
of the pandemic period (April 2009). Of the 505 recruited,
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493 employees were aged between 16 and 65 years and had
complete information (laboratory results and questionnaire
response). It is these 493 respondents who have been used
in all analyses reported here. Serology specimens were tested
for antibodies to influenza A (H1N1) in the West of Scotland
Specialist Virology Centre, Glasgow, using microneutralisa-
tion assays at a dilution of 1 : 40 as previously described [4].
In addition a set of age- and sex-matched blood samples
(n = 471) were obtained from stored serology specimens
collected from HCWs for occupational health purposes
during 2008 (i.e., prepandemic), and these were also tested.
Chi-squared test with Yates’ continuity correction was used
to compare seropositive prevalence in pre- and peak pan-
demic samples and logistic regression analysis to examine the
association of seropositivity with risk group classification.
The study was approved by the Local Regional Ethics Com-
mittee. Sample size needed was calculated as 500, to ensure
a pandemic estimate of seropositivity with 95% confidence
interval no wider than±3.5 percentage points, assuming that
the observed prevalence was 20%.
3. Results
The age and sex profile for pre- and peak pandemic samples
was similar to the overall hospital-based NHS Lothian
workforce, and 67% of pandemic participants were classified
as frontline, the same as the overall HCW workforce.
In the pandemic sample the prevalence of seropositivity
in HCWs was 10.3% (95% confidence interval (CI) 7.7 to
13.0%). This seropositivity was higher than prepandemic
HCW seropositivity rate by 3.7 percentage points (95% CI
0.3 to 7.3 percentage points, P = 0.048). The study was not
powered to test for variation in seropositivity rates across age
bands, but the highest pandemic rate observed was 17.4% in
the youngest age band (16 to 25 years old), whereas prepan-
demic this age band had nearly the lowest rate (4.3%). How-
ever, the small numbers in the youngest age band means that
the diﬀerence in seropositivity (pre versus pandemic) was
not statistically significantly diﬀerent according to whether
comparing within those aged up to 25 years or over 25 years
(P = 0.147).
Occupations were grouped into frontline contact (allied
health professionals, doctors, nurses, midwives, and stu-
dents) and non-frontline contact (administrative, pharmacy,
and support staﬀ including e.g., individuals working in labo-
ratories or “estates”). For pandemic samples, seropositivity
rates for frontline and non-frontline HCWs were similar
overall at 11.0% (95% CI 7.6 to 14.4%) and 9.1% (5.8 to
12.5%), respectively. Influenza-like symptoms in the preced-
ing six months were reported by 208 (42.2%), and 12.0%
(95% CI 7.6 to 16.4%) of them were seropositive, compared
to 9.1% (95% CI 5.8 to 12.5%) of those without recent
symptoms (Table 1).
A trend analysis across three levels of risk (prepan-
demic, pandemic but no influenza-like symptoms, pandemic
reporting symptoms) found a statistically significant trend in
seropositivity (P = 0.018), with a linear odds ratio of 1.39
(95% CI 1.06 to 1.84), suggesting that overall the odds of a
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Figure 1: Seropositivity separately for peakpandemic and prepan-
demic samples, with peakpandemic samples subdivided according
to report or not of influenza-like symptoms (n = 208, 285, 471,
resp.), overall and by age band.
positive laboratory result increased by 39% for each move
from one risk category to the next higher category. Figure 1
shows overall seropositivity for the three risk categories and
across age bands.
4. Discussion
To our knowledge, this is the first study in the UK to quantify
the level of seropositivity to influenza A (H1N1) in unvac-
cinated HCWs pre- and peak pandemic. Our findings have
important implications both for understanding the spread of
influenza A (H1N1) and for planning and delivery of future
pandemic influenza vaccination programmes.
Previous vaccination is indistinguishable from previ-
ous infection on microneutralisation testing, so our active
recruitment of unvaccinated participants for the pandemic
samples avoids the limitation of other studies which did
not have full documentation of vaccination status, many of
which relied on discarded laboratory samples, samples from
blood donors or patients [4–7]. Other studies have looked at
a single time point [4], including one study of HCWs (from
Taiwan) [8], which means that it is not possible to compare
prepandemic immunity observed in other studies [6].
Our study included pre- and pandemic samples which
allowed us to compare peak pandemic seropositivity against
the rate about 9months before the start of the pandemic. The
only other HCW study conducted pre- and midpandemic
that we have identified (from Singapore) used a diﬀerent
assessment of seroconversion, requiring a 4-fold rise in titre
from baseline, so a direct comparison with our findings is not
possible [9].
Elder has reported previously that there is little indi-
cation of increased susceptibility to seasonal influenza by
occupational group, including healthcare [1]. Accordingly,
in the absence of a more general study of seroprevalence
in unvaccinated adults of working age, our estimate of
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pandemic seropositivity is arguably the closest estimate to
date of overall population prevalence in adults in the UK at
that time.
It is important to remember the levels of uncertainty
and concern that existed midpandemic. In October 2009
the Scottish Chief Medical Oﬃcer noted a slower spread
than anticipated [10]. However that same week the United
States declared an influenza A (H1N1) emergency, with 1,000
deaths across 46 states and questions about the ability to cope
with a potential surge in cases [11]. A week later Health Pro-
tection Scotland reported that influenza A (H1N1) related
hospitalisations and deaths in Scotland continued to increase
[12]. Furthermore, the influenza virus’s ability to mutate
and transfer genetic material between strains meant that a
substantial increase in cases over the winter influenza season
remained a possibility. Our findings show that over the first
six months of the pandemic the A (H1N1) strain was of
limited virulence with only around 4% of susceptible HCWs
having developed seropositivity despite 42% participants
reporting flu-like symptoms in preceding months. However,
previous virulence is not necessarily a guide to future spread,
particularly on the cusp of the influenza season, and our
findings show that 90% HCWs were still susceptible to infec-
tion. These findings support the importance of vaccination
even at the peak of a pandemic (and regardless of previous
symptoms), contrasting with findings of a large English study
that sampled patients accessing health care between August
and September 2009 [6].
It has been estimated that between 40 and 50% of HCWs
in the UK were vaccinated for influenza A (H1N1) by
February–April 2010 [13–15]; in Lothian the figure was 52%
[16]. This high level of uptake in HCWs across the United
Kingdom in the weeks following this study means that it
would not be feasible to estimate postpandemic seropositiv-
ity among unvaccinated HCWs. Although in other studies
performed towards the end of the pandemic period the
seroprevalence reported—between 20 and 40% [4, 5, 7]—
was considerably higher than we found, there is uncertainty
about vaccination rates and caveats about study population
in these studies, as described above.
Our study has a number of potential weaknesses. We did
not recruit primary care staﬀ. Self-selection of participants
and the exclusion of HCWs who were targeted first by the
vaccination programme may have led to an under- or over-
estimation of the true level of infection with the virus for all
HCWs in Lothian. Other studies have demonstrated a greater
increase in seropositivity during the pandemic period in
younger adults (16 to 25 years old) compared to older adults,
both in high prevalence areas in the UK [4] and among blood
donors in Australia [5]. While our study showed a similar
pattern of greater increase in seropositivity in younger adults
than other age groups (Figure 1) it was not powered to test
such an interaction hypothesis.
These findings have important implications for research
into future pandemics. Having information on seropreva-
lence in unvaccinated individuals during the pandemic
would have been invaluable and may be feasible in a future
pandemic. Virology samples can be stored indefinitely allow-
ing comparison with samples taken from previous years.
Such information would help identify susceptible age groups,
helping the planning of vaccination campaigns during
the pandemic. We therefore suggest that health protection
organisations consider collecting samples annually from a
representative “panel” of asymptomatic individuals, selected
and powered to allow comparisons by age.
5. Conclusion
In conclusion, our study shows that at pandemic peak 10.3%
of HCWs in Lothian, south east Scotland, were seropositive
for influenza A (H1N1), so the great majority were still
susceptible to influenza A (H1N1) infection at the introduc-
tion of the vaccination programme.
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